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Abstract
Background: Kinins participate in the pathophysiology of obesity and type 2 diabetes by mechanisms which are not fully
understood. Kinin B1 receptor knockout mice (B1
2/2) are leaner and exhibit improved insulin sensitivity.
Methodology/Principal Findings: Here we show that kinin B1 receptors in adipocytes play a role in controlling whole body
insulin action and glucose homeostasis. Adipocytes isolated from mouse white adipose tissue (WAT) constitutively express
kinin B1 receptors. In these cells, treatment with the B1 receptor agonist des-Arg
9-bradykinin improved insulin signaling,
GLUT4 translocation, and glucose uptake. Adipocytes from B1
2/2 mice showed reduced GLUT4 expression and impaired
glucose uptake at both basal and insulin-stimulated states. To investigate the consequences of these phenomena to whole
body metabolism, we generated mice where the expression of the kinin B1 receptor was limited to cells of the adipose
tissue (aP2-B1/B1
2/2). Similarly to B1
2/2 mice, aP2-B1/B1
2/2 mice were leaner than wild type controls. However, exclusive
expression of the kinin B1 receptor in adipose tissue completely rescued the improved systemic insulin sensitivity
phenotype of B1
2/2 mice. Adipose tissue gene expression analysis also revealed that genes involved in insulin signaling
were significantly affected by the presence of the kinin B1 receptor in adipose tissue. In agreement, GLUT4 expression and
glucose uptake were increased in fat tissue of aP2-B1/B1
2/2 when compared to B1
2/2 mice. When subjected to high fat diet,
aP2-B1/B1
2/2 mice gained more weight than B1
2/2 littermates, becoming as obese as the wild types.
Conclusions/Significance: Thus, kinin B1 receptor participates in the modulation of insulin action in adipocytes,
contributing to systemic insulin sensitivity and predisposition to obesity.
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Introduction
As we enter the 21st century, more than 170 million people
worldwide suffer from type 2 diabetes (www.who.int). This
disorder is strongly correlated with obesity, being nine among
ten type 2 diabetic patients also obese or overweight. The interplay
between the pathogenesis of obesity and type 2 diabetes strongly
relies on the endocrine functions displayed by the adipose tissue.
The white adipose tissue (WAT) secretes molecules in response to
metabolic inputs to control key physiological processes of the
organism, including glucose homeostasis, lipid metabolism, energy
balance, inflammation and vascular homeostasis [1,2,3]. Adipo-
nectin, for instance, is an adipocyte-specific hormone that is
elevated in the serum of individuals after weight loss to promote
insulin sensitivity [4,5].
Kinins are peptides that participate in a wide range of
physiopathological processes. Two G protein-coupled receptors
of the rhodopsin family, namely B1R and B2R, have been shown
to bind kinins [6,7]. While the kinin B2R subtype mediates the
action of bradykinin (BK), the B1R subtype is activated by des-
Arg9-BK (DBK), a product of the cleavage of BK by carboxy-
peptidases [6,7]. B2R is ubiquitously expressed, whereas the B1R
subtype is absent in most tissues during basal conditions but is
strongly up-regulated by inflammatory stimuli [6,7,8]. Thus, many
of the physiological functions described for kinins have been
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attributed to the activation of the B2R, while the B1R has been
mainly correlated to pathological processes [6,7,8].
Initial observations proposing a role for kinins in the regulation
of glucose homeostasis date back several decades [9,10]. These
reports showed that BK was produced by the working muscle
where it induces glucose uptake. Recent studies confirmed these
observations in muscle cells [11] and primary adipocytes [12],
showing that stimulation with BK was able to potentiate the
insulin effects on promoting glucose uptake, by inhibiting JNK
activation [13]. In agreement, B2R knockout mice (B2
2/2)
exhibited insulin resistance and glucose intolerance [14].
The observed effects of kinins on glucose homeostasis are
intuitively associated with the activation of the kinin B2R, since
this receptor is ubiquitously expressed. However, a growing body
of evidence supports the participation of B1R in the etiology of
diabetes. In 1999, Zuccollo et al. [15] reported for the first time
that treatment of mice with the kinin B1R specific antagonist
[Leu8]-DBK could prevent hyperglycemia, insulitis and renal
damage induced by low doses of streptozotocin. More recently,
our group showed that the kinin B1R participates in the regulation
of blood glucose levels by promoting the release of insulin by
pancreatic b-cells [16]. Furthermore, mice lacking B1R (B1
2/2)
exhibited improved systemic insulin sensitivity [16] and showed
resistance against high fat diet (HFD)-induced obesity [17].
Treatment with a stable selective B1R antagonist also prevented
rodents from gaining weight on a HFD [17] or on a high glucose
diet [18]. This antagonist was also able to increase whole body
insulin sensitivity and reverse plasma fatty acids composition
changes in a rat model of insulin resistance [18].
Despite the body of evidence that supports a role for the kinin
B1R in obesity and insulin resistance, the mechanisms through
which the B1R participates in the pathogenesis of these diseases
remain unknown. Our group demonstrate that leptin, a cytokine
secreted exclusively by adipocytes, participates in this process [17].
Others showed that the B1R blockade may protect from obesity
and insulin resistance through inhibition of inammation in adipose
tissue. Both hypotheses, which are not exclusive, allude to a
potential role for B1R in adipose tissue.
In the present study we show that stimulation of constitutively
expressed kinin B1R in mouse epididymal adipocytes promotes
glucose uptake by these cells. Accordingly, adipocytes from B1
2/2
mice exhibit reduced activation of key mediators of the insulin
signaling pathway and display decreased glucose uptake. Interest-
ingly, by rescuing the expression of the kinin B1R exclusively in
cells of the adipose tissue, we partially rescue these phenotypes, as
well as the increased systemic insulin sensitivity and the resistance
against HFD-induced obesity of B1
2/2 mice. Taken together, our
results point to an important role for kinin B1R in adipocytes to
modulate local and systemic insulin action and predisposition to
metabolic diseases.
Results
Expression and Functionality of the Kinin B1R in Mouse
Adipocytes
To assess basal expression of kinin B1R in fat versus other
tissues, we performed real-time PCR analysis using total RNA
from different organs of adult male C57Bl/6 mice. As shown in
Figure 1A, epididymal WAT had the highest basal level of B1R
mRNA expression among all tissues analyzed. Stimulation of B1
and B2 receptors with DBK and BK acutely increased acidification
rate of the medium in response to the agonists, demonstrating the
functionality of both receptors in isolated adipocytes (Figure 1B).
In addition, B1
2/2 cells, as well as WT cells treated with the B1
antagonist [Leu8]-DBK, did not respond to DBK induction,
confirming the specificity of the method to detect functional kinin
B1R. Expression of other components of the kallikrein-kinin
system could also be detected in mouse WAT, including B2R,
carboxypeptidase M and tissue kallikrein (Figure 1C), which along
with the previously reported presence of kinin-degrading enzyme
ACE [19], indicates that this system is potentially active in the
adipose tissue. In addition, B1R mRNA was downregulated in
epididymal adipose tissue, as well as in heart of obese versus lean
mice (Figure 1D and Figure S1). Together, these data demonstrate
that the kinin B1R is constitutively expressed in fat of mice,
suggesting a potential participation of this receptor in adipose
tissue function.
Kinin B1R Activation Improves Insulin Sensitivity in Mouse
Adipocytes
BK has been shown to promote insulin sensitivity in adipocytes
via activation of the kinin B2R [12,13,20]. To test the hypothesis
that the agonist of the B1R subtype could also mediate similar
effects on fat cells, we assessed insulin signaling in differentiating
3T3-L1 adipocytes in the presence or absence of DBK. AKT
phosphorylation, an event that occurs within 10 minutes upon
insulin stimulation, was not potentiated by DBK, however
dephosphorylation of AKT, which occurs later during the time-
course, was abrogated in cells pre-incubated with the B1R agonist
(Figure 2A). Furthermore, insulin-induced ERK phosphorylation
was increased by over 2-fold with DBK treatment (Figure 2A).
Consistent with this, pre-incubation of 3T3-L1 adipocytes with
DBK for 90 minutes significantly increased insulin-induced
association of the p85 regulatory subunit of PI3K to IRS1, an
event that precedes AKT phosphorylation (Figure 2B). In
addition, DBK was able to potentiate insulin-induced GLUT4
translocation to the plasma membrane in 3T3-L1 adipocytes
(Figure 2C) and insulin-induced glucose uptake by isolated
adipocytes (Figure 2D). DBK alone did not affect glucose uptake,
suggesting an insulin dependent phenomenon. In agreement,
incubation of 3T3-L1 adipocytes with DBK significantly aug-
mented insulin-induced increase in cell acidification rate (4.5 fold,
P,0.05), which again demonstrates the positive effect of B1R
stimulation on insulin action in fat cells (Figure 2E). We further
investigated insulin signaling and the regulation of GLUT4
translocation and glucose uptake in adipocytes from B1
2/2 and
WT mice. Interestingly, AKT phosphorylation during random fed
states was dramatically reduced in B1
2/2 versus WT mice, but no
difference was observed between these mice in response to acute
insulin stimulation (Figure 2F). Moreover, GLUT4 translocation
to the plasma membrane (Figure 2G) and glucose uptake
(Figure 2H) were significantly reduced in B1
2/2 isolated
adipocytes in comparison to WT, most evidently at basal states,
but also during insulin-stimulated states. These results demonstrate
that the kinin B1R modulates the basal status of activation of the
insulin signaling pathway in mouse adipocytes, affecting glucose
uptake by these cells.
To investigate whether these effects were restricted to the
adipose tissue, we measured accumulation of [3H]-2-deoxy-
glucose in different insulin responsive organs of B1
2/2 and WT
mice (Figure 2I). Consistently, glucose uptake by the WAT of
B1
2/2 mice was significantly decreased in comparison to the
WAT ofWTmice. On the other hand, glucose accumulation by the
heart was elevated in B1
2/2 mice when compared to WT animals.
Generation and Characterization of aP2-B1/B1
2/2 Mice
In order to study the importance of kinin B1R expression to
adipose tissue function and whole body metabolism, we generated
Adipocyte Kinin B1 Receptor Function in Metabolism
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mice with exclusive expression of B1R in adipose tissue. To direct
adipose tissue-specific expression, the coding region of the mouse
kinin B1R gene was cloned downstream of the adipose-specific aP2
promoter (Figure S2A). This construct was injected into the pro-
nuclei of C57BL/6 mouse oocytes and positive founders were
screened by PCR (Figure S2B) and Southern Blotting (Figure
S2C). At least two transgenic lines were generated, but line 25 was
chosen to be crossed to B1
2/2 mice to originate aP2-B1/B1
2/2
mice due to high expression levels of the transgene in all fat depots
analyzed (Figure S2D). In addition, binding assays demonstrated
the presence of kinin B1R in the membrane of aP2-B1/B1
2/2
isolated adipocytes (Figure S2E). Finally, stimulation of aP2-B1/
B1
2/2 adipocytes with DBK was able to augment basal cellular
metabolism, indicating a functional rescue of kinin B1R in the fat
cells of aP2-B1/B1
2/2 mice (Figure S2F).
Selective Expression of Kinin B1R in Adipocytes Rescues
Gene Expression Patterns and Glucose Uptake of B1
2/2
Mice
Ablation of kinin B1R had a substantial impact on gene
expression in adipose tissue, as revealed by microarrays followed
by Gene Set Enrichment Analysis (GSEA) [21] (Figure S3A). To
determine how the exclusive expression of the kinin B1R in
adipose tissue could rescue these patterns, we compared B1
2/2
and aP2-B1/B1
2/2. Interestingly, some gene sets found to be
differentially expressed between WT and B1
2/2 were also found
to be differently expressed between aP2-B1/B1
2/2 and B1
2/2,
including the ‘‘DNA Dependant ATPase Activity’’ and ‘‘Detection
of External Stimulus’’ gene sets (Table S1).
To investigate more specifically the pathways associated with
insulin signaling, we generated heat maps to display genes that are
known to be regulated by insulin (Figure S3B). In B1
2/2 mice,
many of these genes were downregulated in comparison to WT,
and part of this pattern was rescued in aP2-B1/B1
2/2 mice. To
elaborate and validate these observations, we measured the
expression of GLUT4 (Figure 3A) and other genes involved in
glucose and lipid metabolism (Figure S4) by real-time PCR.
Accordingly, the expression of GLUT4 was reduced by 5-fold in
B1
2/2 when compared to WT and completely rescued in aP2-B1/
B1
2/2 mice (Figure 3A). GLUT1, on the other hand, was reduced
in both B1
2/2 and aP2-B1/B1
2/2 mice in comparison to WT
mice (Figure S4). As a surrogate for a functional readout, we also
measured GLUT4 translocation in adipose tissue (Figure 3B) and
glucose uptake in isolated adipocytes (Figure 3C). The total lack of
kinin B1R impaired both basal GLUT4 expression in the plasma
membrane as well as basal glucose uptake, but the presence of
these receptors exclusively in adipocytes was able to rescue these
phenotypes. Consistently, the aP2-B1 transgene also rescued the
decreased basal AKT phosphorylation of B1
2/2 mice (Figure 3D).
Together, these results demonstrate that the kinin B1R regulates
the insulin signaling pathway in adipose tissue.
In certain situations where the kinin B1R is absent, the B2R is
shown to be upregulated [22], which led us to ask whether the
expression of this receptor was affected by the ablation of the B1R,
possibly supporting an effect on insulin signaling. However, despite
a trend towards an increase in kinin B2R mRNA expression in the
aP2-B1/B1
2/2 mice versus the WT or the B1
2/2 mice, no
significant differences were observed among the groups (Figure
Figure 1. The kinin B1R is constitutively expressed in WAT and downregulated with obesity. A: Kinin B1R mRNA expression was
quantified in different organs of male C57Bl/6 mice (n = 5) using TaqMan real-time PCR. Data are expressed as mean6SEM of the 22DCt parameter,
which represents the relative expression of B1R mRNA in relation to b-actin mRNA. WAT, white adipose tissue; ND, non-detectable; a.u., arbitrary units.
B: Effects of acute treatment with the B1R agonist des-Arg
9-bradykinin (DBK), the B2 receptor agonist bradykinin (BK) or DBK in the presence of the
B1R antagonist [Leu
8]-DBK on the extracellular acidification rate of isolated adipocytes from wild type (WT) and B1 knockout (B1
2/2) mice (n = 5
animals per group) measured using the Cytosensor system. C: Representative RT-PCR showing expression of components of the kallikrein kinin system
kallikrein in WAT, lung, and heart of C57Bl/6 male (n = 3). KK, tissue kallikrein; CPM, carboxypeptidase M; B2, kinin B2 receptor. C-, negative control. D:
C57BL/6 mice were submitted to HFD for 9 weeks (n = 5 per group). Kinin B1R expression was quantified in WAT by real time PCR. Results are mean6
SEM. *, P,0.05.
doi:10.1371/journal.pone.0044782.g001
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S3C), indicating that alterations in B2R expression are not
sufficient to explain how modulation of the B1R affects insulin
sensitivity in adipose tissue.
aP2-B1/2B1
2/2 Mice are Lean but Insulin Resistant
Next, we wanted to determine how the expression of kinin B1R
in adipocytes could impact whole body metabolism. Under chow
diet, body weight (Figure 4A), food intake, spontaneous activity
and body temperature of aP2-B1/B1
2/2 mice were similar to
B1
2/2 mice (Table S2). However, despite the number of pathways
that appeared to be rescued in adipose tissue of aP2-B1/B1
2/2
mice, these mice were leaner than the WT (22.3% leaner) and as
lean as the B1
2/2 (Figure 4B). Liver and kidney weights were also
reduced in B1
2/2 and aP2-B1/B1
2/2 mice, suggesting decreased
glycogen and/or fat storage in these organs (Figure 4C). However,
epididymal fat pad weight was slightly higher in aP2-B1/B1
2/2
mice versus B1
2/2 mice (Figure 4C). Surprisingly, morphological
analysis of this fat depot revealed smaller adipocytes in aP2-B1/
B1
2/2 mice in comparison to WT mice or B1
2/2 (Figure 4D and
E). On the other hand, the number of adipocytes in the epididymal
fat depot of aP2-B1/B1
2/2 mice was increased in comparison to
the WT (,6-fold) and to B12/2 mice (,2-fold) (Figure 4F). To
Figure 2. Kinin B1R modulates insulin action in mouse adipocytes. A: AKT and ERK phosphorylation upon stimulation of differentiating 3T3-
L1 preadipocytes with 10 mg/mL insulin (in the presence of 1 mM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine and 10% FBS). *, P,0.05; vs.
non-stimulated; #, P,0.05: vs. insulin only. The blots and quantification are one representative experiment out of three performed independently. B:
3T3-L1 adipocytes were incubated with or without 1 mM DBK for 90 minutes prior to 10 min stimulation with 1 mg/mL insulin. Cells were harvested
for immunoprecipitation (IP) followed by immunoblotting (IB) or C: membrane fractionation for assessment of GLUT4 translocation by western
blotting. *, P,0.05; vs. non-stimulated; #, P,0.05: vs. insulin only. The blots and quantification are one representative experiment out of two
performed independently. D: Isolated epididymal adipocytes of WT mice were incubated with 5 mM glucose media with or without 1 mM DBK for 90
minutes and [3H]-2-deoxy-glucose accumulation was measured under basal conditions or after 15 min stimulation with 10 nM insulin. Data represent
mean 6 SEM of at least 8 independent samples obtained from an adipocyte pool of 15 animals. *, P,0.05 vs. respective control. E: Effect of 90
minutes incubation with 1 mM DBK on the insulin-induced extracellular acidification rate of 3T3-L1 adipocytes measured by Cytosensor system (*,
P,0.05; n = 4 per group). Data represent mean6 SEM of extracellular acidification. F: Random fed WT or B1
2/2 mice (n = 4 per group) were injected in
the vena cava with either saline or a 10 U insulin bolus. Epididymal fat was harvested after 10 minutes for assessment of AKT phosphorylation by
western blotting or G: GLUT4 translocation. H: Glucose uptake was assessed in isolated epididymal adipocytes of WT and B1
2/2 cells under basal
conditions or after 15 min stimulation with 10 nM insulin. Data represent mean6 SEM of at least 8 independent samples obtained from an adipocyte
pool of 15 animals. *, P,0.05; **, P,0.001 vs. respective control. I: Fasted mice received 0.2 U human insulin per kg, 0.083 mCi [3H]-2-deoxy-glucose
per kg was subcutaneously injected, mice were sacrificed and tissue collected. Data show mean 6 SEM of 5 animals per genotype. *, P,0.05.
doi:10.1371/journal.pone.0044782.g002
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assess the rate of lipogenesis in the adipose tissue of these animals,
we isolated adipocytes from epididymal fat depots and measured
incorporation of glucose into triglycerides (Figure 4G). Basal
lipogenesis was not different between groups, but insulin-
stimulated lipogenesis was decreased in both aP2-B1/B1
2/2 and
B1
2/2 mice when compared to WT. When comparing aP2-B1/
B1
2/2 and B1
2/2 mice to WT mice, although the values did not
reach statistical significance, they revealed a strong tendency to be
reduced (Figure 4G). Consistently, the expression of the mRNA of
lipogenic enzymes such as fatty acid synthase (FAS) and acetyl-
CoA carboxylase (ACC) was reduced in aP2-B1/B1
2/2 and
B1
2/2 mice in comparison to WT mice (Figure S4). Basal and
isoproterenol-induced lipolysis was also reduced in B1
2/2 mice
(Figure 4H). However, exclusive kinin B1R expression in
adipocytes could partially rescue this phenotype, since the basal
lipolysis in aP2-B1/B1
2/2 adipocytes was not significantly
different from the WT controls. On the other hand, isoproterenol
did not stimulate lipolysis in aP2-B1/B1
2/2 as in WT mice and the
rate of lipolysis remained similar to B1
2/2 animals (Figure 4H).
Furthermore, we investigated the impact of these changes to blood
lipid and cholesterol levels of these animals. These modest, but
significant alterations (Table S3), namely, lower HDL cholesterol
and higher LDL cholesterol levels in B1
2/2 mice in comparison to
WT mice were rescued in aP2-B1/B1
2/2 mice. These results
suggest that the kinin B1R in adipocytes might play a role in lipid
turnover and participate in the pathogenesis of cardiovascular
diseases [23].
Reduced fat mass is usually accompanied by an improvement in
systemic insulin sensitivity. Thus, despite insulin resistance in
adipose tissue, B1
2/2 mice exhibited improved whole body insulin
sensitivity and decreased serum insulin levels in comparison with
WT mice [16]. Interestingly though, aP2-B1/B1
2/2 mice were as
insulin sensitive as WT mice despite showing reduced fat mass and
smaller adipocytes (Figure 5A and C). However, these mice
showed impaired glucose tolerance when compared to the WT
controls (Figure 5B). These data inversely correlate with the
expression of adiponectin mRNA in adipose tissue (Figure 5D),
which has been shown to be a bona-fide marker for whole body
insulin sensitivity in mice and humans [4]. Thus, these data
suggest that signaling through the kinin B1R in adipocytes
regulates systemic insulin resistance independently on the adiposity
status of the organism. Also, they reinforce the notion that whole
body insulin sensitivity correlates inversely with selective adipose
tissue insulin sensitivity, a phenomenon that is corroborated by
several other studies [24,25,26,27].
Kinin B1R Expression in Adipocytes Controls
Predisposition to Obesity
B1
2/2 mice are protected against obesity induced by HFD [17]
and insulin action in fat has been shown to be required for age-
related and hypothalamic lesion-induced obesity [27]. Given the
role of B1R in regulating insulin signaling in adipocytes, we asked
whether its constitutive expression in fat could contribute to the
pathogenesis of obesity. We therefore monitored body weight gain
and adiposity of aP2-B1/B1
2/2, B1
2/2, and WT mice subjected
to HFD for 21 weeks. After 7 weeks on HFD, body weights of aP2-
B1/B1
2/2 and B1
2/2 mice were significantly lower than WT
controls (Figure 6A). However, aP2-B1/B1
2/2 mice progressively
gained weight as mice were maintained on HFD and ended up
Figure 3. Rescue of kinin B1R expression in adipocytes of kinin B1R knockout mice (B1
2/2) partially rescues GLUT4 expression and
function in adipose tissue. A: Expression of GLUT4 mRNA in epididymal fat of random fed mice measured by realtime PCR. B: GLUT4 translocation
in epididymal fat at basal states or after insulin stimulation (10 U intravenous bolus for 10 min). The blots and quantification are one representative
experiment out of two performed independently. C: Basal glucose uptake in isolated adipocytes. [3H]-2-deoxy-glucose accumulation was measured
during 5 minutes. Data represent mean 6 SEM of six animals per group. D: Basal AKT phosphorylation in the epididymal fat of random fed mice. The
blots and quantification are one representative experiment (pool of 4–5 mice each) out of two performed independently. *, P,0.05; **, P,0.001.
doi:10.1371/journal.pone.0044782.g003
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matching the values of the WT. On the other hand, B1
2/2 mice
were significantly lighter than the WT throughout the whole diet
(Figure 6A). After 4 months under HFD, mice were sacrificed and
epididymal fat was weighed, revealing a complete rescue of
adiposity in aP2-B1/B1
2/2 mice (Figure 6B). This was linked to
atypical hyperplasia of adipocytes in adipose tissue of aP2-B1/
B1
2/2 mice (Figure 6C), but not adipocyte hypertrophy (Figure
S5). Glucose tolerance test also showed that aP2-B1/B1
2/2 mice
were more glucose intolerant than WT mice after HFD
(Figure 6D), even though the level of adiposity was similar
between these two groups. These results indicate that the presence
of the kinin B1R in adipocytes contributes to fat accumulation and
insulin resistance in response to HFD.
Discussion
In most physiological processes associated with the kallikrein-
kinin system, the B1R is attributed a secondary role, probably due
to the fact that this receptor is absent or very low expressed in most
mammalian cell types [6,7]. Our results show that under
physiological conditions the kinin B1R is functionally expressed
in adipose tissue of mice and, similarly to the B2R, can promote
insulin signaling and glucose uptake in these cells. Our findings do
not only define the kinin B1R and the bioactive metabolites of BK
as important physiological mediators, but also contribute to the
understanding of the mechanisms underlying the effects of kinins
on the regulation of glucose homeostasis.
Kinin B1 and B2 receptors interact with Gq and Gi proteins to
activate redundant signaling pathways that include phosphatidy-
linositol hydrolysis, elevation of intracellular Ca2+, arachidonic
acid release, eicosanoid production, as well as endothelial nitric
oxide synthase (eNOS) activation and nitric oxide production
[6,7]. It is assumed that in situations where the two kinin receptors
are co-expressed they may act synergistically to mediate similar
cellular processes [6,7]. However, due to differences in expression
pattern and post-activation desensitization between these recep-
tors, the situations when they may act synergistically are normally
restricted to pathological conditions when the B1R are abundantly
expressed. According to our results, this synergism may happen
under physiological conditions in adipocytes. Thus, we surmise
that the regulation of insulin action in fat cells by kinin receptors
Figure 4. aP2-B1/2B1
2/2 mice are lean. A: Body weight. B: Body composition. *, P,0.05 vs. B1
2/2 and aP2-B1/B1
2/2, fat mass comparison; #,
P,0.05 vs. WT, lean mass comparison. C: Organ weight. D: Histology of adipose tissue (H&E staining). Representative pictures of at least five animals
per group. E: Adipocyte volume. F: Adipocyte number. G: Basal and maximum (insulin-stimulated) lipogenesis in isolated adipocytes. H: Basal and
isoproterenol-induced lipolysis as determined by glycerol production by isolated adipocytes. Values are means 6 SEM of six animals per group. *,
P,0.05; **, P,0.001.
doi:10.1371/journal.pone.0044782.g004
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are mediated by a congruent mechanism, most likely involving
eNOS-mediated inhibition of Jun NH2-terminal kinase [13].
Even though sharing similar functions, kinin receptors may play
different roles. This is supported by a body of evidence showing
that phenotypes observed in B1
2/2 mice are often antagonistic to
those observed in B2
2/2 mice. For example, while B2
2/2 mice
exhibit normoglycemia, hyperinsulinemia and systemic insulin
resistance [14], B1
2/2 mice are hypoglycemic, hypoinsulinemic
and more tolerant to the systemic effects of insulin. Most likely,
these differences may be related to differences concerning the
expression pattern of these receptors. In this study, we bring
further evidence to support this hypothesis. Here we show that the
kinin B1R is expressed in WAT of mice under normal conditions
where it promotes local insulin signaling and increases local
Figure 5. Kinin B1R in adipocytes contributes to glucose homeostasis. A: Insulin tolerance test; *, vs. WT and B1
2/2. B: Glucose tolerance test;
*, vs. WT and B1
2/2. C: Serum insulin levels. D: Adiponectin expression as quantified by realtime PCR. Values are means 6 SEM of six animals per
group. *, P,0.05.
doi:10.1371/journal.pone.0044782.g005
Figure 6. Kinin B1R in adipocytes contributes to fat accumulation and insulin resistance in response to a high fat diet (HFD). Animals
were submitted to HFD. A: Body weight was monitored during the diet. *, vs. aP2-B1/B1
2/2; B: Mice were sacrificed at the end of the treatment and
the epididymal fat pads were weighed. C: Adipocyte number was quantified in the epididymal fat pad. D: Glucose tolerance was performed 12 weeks
after the beginning of the HFD; *, aP2-B1/B1
2/2 vs. B1
2/2 and WT. Values are means 6 SEM of six animals per group. *, P,0.05.
doi:10.1371/journal.pone.0044782.g006
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glucose uptake. Insulin plays important regulatory roles in the
adipose tissue controlling glucose and lipid utilization, adipocyte
differentiation and the expression of adipocyte-derived hormones
that regulate whole body metabolism [1,2,28]. Thus, proper
insulin action at the level of the adipose tissue is thought to be
required for normal metabolic homeostasis, which include the
regulation of whole body insulin sensitivity, the susceptibility to
obesity, and the relationship between plasma leptin and body
weight [27]. Several animal models corroborate this view and
suggest that selective insulin resistance in adipocytes can be
otherwise considered an etiological factor leading to improved
systemic insulin responsiveness and protection against HFD-
induced obesity.
For example, in fat-specific insulin receptor knock-out mice
(FIRKO), severe insulin resistance in adipocytes results in leanness
and robust protection against obesity and glucose intolerance [27].
Also, specific ectopic expression of a transmembrane isoform of
TNFa in adipocytes is able to decrease whole body adipose mass
and induce local insulin resistance, while promoting systemic
insulin sensitivity [26]. Overexpression of the suppressor of
cytokine signaling 3 in adipocytes equally results in local insulin
resistance despite increasing whole body glucose tolerance [25].
Moreover, glutamine supplementation, which was shown to
specifically induce insulin resistance in the adipose tissue of rats
under HFD, also leads to amelioration of insulin action in other
insulin responsive organs [24].
Here we show that kinin B1R in adipocytes contribute to the
regulation of systemic insulin sensitivity and predisposition to
HFD-induced obesity. By rescuing the expression of these
receptors in adipocytes of B1
2/2 mice, basal insulin signaling
and glucose uptake are rescued in these cells. As a consequence,
whole body insulin sensitivity of aP2-B1/B1
2/2 is normalized to
the WT levels, despite lower adiposity. Due to adipocyte-specific
kinin B1R expression, aP2-B1/B1
2/2 mice also gain more weight
than B1
2/2 mice on a HFD.
The adipose tissue relies on the production of adipokines to
mediate the endocrine functions that regulate whole body
metabolism. Adipokines are strongly regulated by insulin and by
the metabolic status of the adipocytes [1,2,3,28]. For example,
adipose tissue insulin resistance in rats fed with a glutamine-
supplemented diet is accompanied by reduced TNFa and
interleukin-6 levels, as well as augmented adiponectin levels,
which seem to be the cause of increased insulin sensitivity in other
organs [24]. Adiponectin is an anti-diabetic hormone produced
exclusively by adipocytes which improves glucose utilization and
reverses insulin resistance associated with obesity [4]. Decreased
expression of adiponectin correlates with insulin resistance in
mouse models of altered insulin sensitivity [4,5]. In B1
2/2 mice,
adiponectin expression is increased and may therefore contribute
to the improved systemic insulin sensitivity of these mice.
However, in aP2-B1/B1
2/2 mice, despite being as lean as
B1
2/2 mice, adiponectin expression levels are similar to the WT.
In a recent report, Dias and Couture [18] demonstrated that
pharmacological blockade of the B1R protected rats against
obesity and insulin resistance, and that these phenotypes were
associated with decreased inflammation in retroperitoneal adipose
tissue. Given the close link between insulin resistance and
inflammation in adipose tissue, one might expect, based on these
data, that B1
2/2 mice would exhibit local insulin sensitivity,
whereas we have observed the opposite phenotype. This apparent
discrepancy might be related to species or depot heterogeneity,
since Dias and Couture used retroperitoneal adipose tissue of rats
while we use epididymal adipose tissue of mice. These differences
are rather significant to the phenotype, since the B1R is absent in
retroperitoneal adipose tissue of rats but is constitutively present in
epididymal adipose tissue of mice. Nevertheless, both studies agree
with the importance of the B1R in controlling adipose tissue
function and regulating whole body susceptibility to insulin
resistance and obesity.
In summary, we demonstrate that kinin B1R are constitutively
expressed in adipocytes and control insulin signaling, glucose
uptake, FFA synthesis (via lipolysis) and adiponectin expression in
these cells. The roles of B1R in adipocytes have systemic
contributions to metabolic homeostasis, since exclusive expression
of these receptors in fat cells is able to control whole body insulin
sensitivity and predisposition to obesity. These data highlight the
importance of kinins in the pathogenesis of diabetes and bring
forth novel and more specific targets for clinical interventions.
Materials and Methods
Animals
B1
2/2 mice [29] were backcrossed for 10 generations with
C57Bl/6 mice (Taconic, Germantown, NY). Animals were
obtained from the Federal University of Sa˜o Paulo, Brazil and
from the Max-Delbru¨ck-Center for Molecular Medicine, Berlin-
Buch, Germany. All experiments reported were conducted as
stated in the National Institutes of Health guide for the care and
use of laboratory animals (Institute of Laboratory Animal
Resources, National Academy Press, Washington DC, 1996) and
approved by a local animal care and use committee. Animals were
maintained on standard mouse chow diet at 22uC on 12 h light-
dark cycle allowed ad libitum access to food and tap water. Adult
males were used in all experiments. Food consumption and body
weight were monitored weekly in single-caged animals.
Cell Culture
3T3-L1 cells were grown in culture dishes containing DMEM
(Invitrogen) with 25 mM glucose and 10% fetal bovine serum
(FBS) (Invitrogen) at 37uC under a 5% CO2 atmosphere. For
adipocyte differentiation, cells were maintained at total confluence
for two days before switching the medium to DMEM with 25 mM
glucose containing 10% FBS, 10 mg/mL insulin, 1 mM dexameth-
asone, and 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich).
After two days, differentiation medium was replaced by DMEM
with 25 mM glucose containing 10% FBS and 10 mg/ml of
insulin, and exchanged every second day. After four days,
differentiated adipocytes were used for subsequent experiments.
Microphysiometer Analysis
Adipocytes were isolated from epididymal fat pads [30] and
56105 isolated adipocytes were fixed in agarose matrix (Molecular
Devices). The alterations in pH of the medium as a consequence of
basal cellular metabolism was measured every 2 minutes using the
Cytosensor microphysiometer [31] (Molecular Devices). Under
continuous pH monitoring, we exposed cells acutely (10 s) to 1 mM
DBK or BK (Bachem) and measured the variation of acidification
rate of the medium, which reflected the pharmacological response
of the cells to the agonist. 16106 3T3-L1 adipocytes were also
coupled to the microphysiometer and stimulated with 10 nM of
insulin prior to and after incubation with 1 mM DBK. We
quantified the differences in insulin-induced alterations of basal
metabolism of cells after chronic stimulation of the kinin B1R.
Glucose Uptake
In ex vivo experiments, isolated adipocytes were incubated for 1
hour in the presence or absence of 10 nM insulin. Basal and
insulin-stimulated rates of [3H]-2-deoxy-glucose accumulation
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were evaluated [32]. In order to assess in vivo [3H]-2-deoxy-glucose
accumulation by different organs, mice were fasted for 12 hours
prior to the beginning of the experimental procedures. Conscious
animals were given a subcutaneous injection of 0.083 mCi [3H]-2-
deoxy-glucose per kg body weight followed after 10 minutes by an
intraperitoneal injection of 0.2 U human recombinant insulin per
kg body weight. One hour after the first injection, mice were
sacrificed by decapitation for collection of blood and organs. After
weighing, organs were homogenized in scintillation medium and
b-emission was analyzed using a Packard b-counter. b-counts in
organ homogenates were normalized by organ weight and then
divided by the b-counts in serum.
Lipolysis and Lipogenesis Assays
Assays in isolated adipocytes were performed as described [33].
As a surrogate for lipogenesis, we measured the incorporation of
D-[U-14C]-glucose into lipids at basal and in response to insulin
(10 nmol/L). Lipolysis was estimated by the quantification of
glycerol released in the incubation medium by isolated adipocytes
at basal and isoproterenol (1025 M) stimulated conditions.
Binding Assays
Isolated adipocytes were transferred to 6-well culture plates
(26106 cells/well) 24 h prior to the beginning of the assay.
Experiments were performed at 4uC and initiated by the addition
of 50 pM [3H]-Des–Arg10–kallidin in the presence of various
amounts of unlabeled peptides as competitors. The binding buffer
consisted of 25 mM Tris–HCl, pH 7.4, including 5 mM MgCl2,
0.1% bovine serum albumin, and 100 mg/ml bacitracin (Sigma,
St. Louis, MO, USA). All measurements were performed in
duplicate. The competition binding profiles were analyzed by
nonlinear regression analysis using PRISM 5 (Graph-Pad5
Software) [34].
Gene and Protein Expression
RT-PCR and Western blotting were performed as described
elsewhere [17].
Membrane Fractioning
Cells and tissues were homogenized in cold buffer A (250 mM
sucrose; 10 mM tris pH 7.4; 0.5 mM EDTA; Complete protease
inhibitors), homogenates were centrifuged at 16,0006g for
20 min, pellets were resuspended in the same buffer and layered
on top of buffer B (1.12 M sucrose; 10 mM tris pH 7.4; 0.5 mM
EDTA). Samples were centrifuged at 158,0006g for 20 min, the
interface was removed with a syringe, diluted in buffer A, and
centrifuged at 74,0006g for 9 min. The pellet from this
centrifugation, containing the plasma membrane fraction, was
resuspended in TNET buffer (1% triton X-100; 150 mM NaCl;
20 mM tris pH 8.0; 2 mM EDTA). The supernatant from the
initial centrifugation was recentrifuged at 43,0006g for 30 min.
The resultant supernatant was centrifuged at 39,0006g for 75 min
and the pellet, containing the low density microsomes fraction, was
resuspended in TNET buffer [35].
RNase Protection Assay and Southern Blotting
Expression of the aP2-B1 transgene was determined using
RNase protection assay (RPA III kit, Ambion). The probe
corresponded to the antisense transcript resulted of the amplifi-
cation of the transgene using the following primers: 59-
TGGACTTCAGAGGCTCATAG-39 and 59-CCAG-
CAACCTGTAGCGGTCC-39. The PCR fragment was cloned
into pGEM-T Easy vector and used as template for in vitro
transcription. For Southern Blotting, the same PCR fragment was
purified through a silica gel column and labeled with a-[32P]-CTP
using the Prime-It kit Random Primer Labeling RmT (Ambion).
Genomic DNA was digested with Sac I and subjected to 1%
agarose gel electrophoresis. DNA was depurinized, neutralized
and then transferred by capillarity to a Hybond-N nylon
membrane (GE Healthcare) and cross-linked using UV. The
membrane was incubated overnight at 62uC with 50 mM Tris
pH 8.0, 10 mM EDTA, 56SSC, 16Denhardt’s, 0.2% SDS,
100 mg/mL salmon sperm DNA containing the labeled probe.
After a series of washes with a gradient of SSC and SDS, the
membrane was exposed to a film and developed using a
PhosphoImager (Fuji).
Generation of aP2-B1/B12/2 Mice
Mice with adipose tissue overexpression of kinin B1R were
generated by pro-nuclear injection of a construct in which the
expression of the kinin B1R gene was driven by the promoter/
enhancer element of the aP2 gene [36] (Figure S1A). Transgenic
mice were backcrossed to B1
2/2 mice to generate aP2-B1/B1
2/2
lines.
Microarray Analysis
Microarray analysis was performed as previously described [37].
RNA samples from four independent mice per group were used
for cRNA synthesis using Affymetrix cRNA Amplification Kit.
cRNA was hybridized onto Affymetrix Genechips M430 2.0.
Gene Set Enrichment Analysis (GSEA) was performed using
GSEA software (Broad Institute, Cambridge, MA).
Diets, Metabolic Tests, and Lipid Profiling
Twelve-week-old mice were fed with standard diet (10% kCal
fat) or high-fat diet (HFD) (45% kCal fat) (Research Diets). After
the treatment, mice were fasted for 12 hours and sacrificed for
collection of blood and tissue samples. To perform glucose and
insulin tolerance tests mice were fasted overnight and injected
intraperitoneally with either 1g glucose or 0.5U insulin (Humalog)
per kg body weight. Blood glucose levels were measured using the
Accu-Chek Advantage glucometer (Roche). Serum lipid profiles
were determined using colorimetric methods (Labtest). Body
temperature was measured using a rectal thermometer (YSI
mod. 4000). Spontaneous activity signals of freely moving mice
were computed at 10-s intervals using a computer-assisted data
acquisition program (ADDENFI metabolic chamber prototype).
Body composition analysis was performed by dual-energy X-ray
absorptiometry using a Hologic QDR 4500 scanner [17].
Statistical Analysis
Values are mean 6 SEM. Statistical analyses were performed
using the two-tailed Student’s unpaired t test to compare two
independent groups, or ANOVA followed by Bonferroni’s test to
compare more than two. Significance was considered at P,0.05.
Supporting Information
Figure S1 Kinin B1R mRNA expression in tissues of
high fat diet treated mice. C57BL/6 mice were submitted to
HFD for 9 weeks (n = 3–4 per group). Kinin B1R expression was
quantified in the tissues by real time PCR. Results are mean 6
SEM. *, P,0.05. Gastrocnemius muscle was studied.
(TIF)
Figure S2 Generation and characterization of aP2-B1/
B12/2 mice. A: pBSaP2B1pA plasmid harboring the aP2-B1
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transgene. The 5.6 kb aP2 promoter/enhancer element (aP2
prom) was cloned upstream of the kinin B1 receptor coding region
(B1) followed by the SV40 poly-adenylation site (pA). B: Tail DNA
PCR genotyping fragments displaying two transgenic colony
founders (25 and 18). pBSaP2B1pA was used as a positive control.
C: The genomic DNA of the two founders was isolated and
southern blotting was performed to confirm the insertion of the
transgene into the genome. pBSaP2B1pA was used as a positive
control. D: RNAse Protection Assay was performed to assess the
expression of the aP2-B1 transgene in different organs. L32 was
used as the loading control. E: Des-Arg9-bradykinin (DBK)
binding assays performed in isolated adipocytes. Values are means
6 SEM of six animals per group. F: Effects of acute treatment with
DBK, the B2 receptor agonist bradykinin (BK) or DBK in the
presence of the B1 receptor antagonist [Leu8]-DBK on the
extracellular acidification rate of isolated adipocytes from wild type
(WT), B1 knockout (B12/2) and aP2-B1/B12/2 mice (n= 5
animals per group) measured by the Cytosensor system.
(TIF)
Figure S3 Expression of kinin B1 receptor in fat
substantially affects adipose tissue gene expression
profile. A: Heat map displaying gene expression in adipose
tissue of wild type (WT), B1
2/2 (KO) and aP2-B1/B1
2/2
(KO_aP2-B) as assessed by Affymetrix microarrays and analyzed
by the Gene Set Enrichment Analysis tool. B: Heat map displaying
gene expression of members of the insulin signaling pathway (as
annotated in the Kyoto Encyclopedia of Genes and Genomes) in
adipose tissue of wild type (WT), B1
2/2 (KO) and aP2-B1/B1
2/2
(KO_aP2-B). C: Kinin B2 receptor mRNA expression in the
adipose tissue based on Affymetrix microarray analysis. Red,
upregulated; Blue, downregulated vs. average of samples.
(TIF)
Figure S4 Lipid and glucose metabolism genes are not
rescued by expression of kinin B1 receptor in fat.
Expression of GLUT1, fatty acid synthase (FAS), acetyl-CoA
carboxylase (ACC) and glycerol-3-phosphate acyltransferase-like
(GPAT) mRNA in epididymal fat of random fed mice measured
by realtime PCR. Data represent mean 6 SEM of six animals per
group. *, P,0.05; **, P,0.001.
(TIF)
Figure S5 aP2-B1/B12/2 mice have smaller adipo-
cytes. Animals were submitted to HFD and adipocyte size was
estimated in histological sections of the epididymal fat pad. Values
are means 6 SEM of six animals.
(TIF)
Table S1 Gene Set Enrichment Analysis. Gene sets downreg-
ulated in B12/2 mice adipose tissue versus WT and aP2B1-
B12/2 adipose tissue.
(XLSX)
Table S2 Energy parameters.
(XLSX)
Table S3 Lipid parameters in the blood.
(XLSX)
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